"Mice, Inbred BALB C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research.
| Descriptor ID |
D008807
|
| MeSH Number(s) |
B01.050.050.199.520.520.338 B01.050.150.900.649.313.992.635.505.500.400.338
|
| Concept/Terms |
Mice, Inbred BALB C- Mice, Inbred BALB C
- BALB C Mouse, Inbred
- Inbred BALB C Mice
- Mouse, BALB C
- BALB C Mouse
- Mouse, Inbred BALB C
- Mice, BALB C
- BALB C Mice
- BALB C Mice, Inbred
- Inbred BALB C Mouse
|
Below are MeSH descriptors whose meaning is more general than "Mice, Inbred BALB C".
Below are MeSH descriptors whose meaning is more specific than "Mice, Inbred BALB C".
This graph shows the total number of publications written about "Mice, Inbred BALB C" by people in this website by year, and whether "Mice, Inbred BALB C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 33 | 33 |
| 1995 | 0 | 34 | 34 |
| 1996 | 0 | 39 | 39 |
| 1997 | 0 | 35 | 35 |
| 1998 | 1 | 34 | 35 |
| 1999 | 0 | 27 | 27 |
| 2000 | 0 | 40 | 40 |
| 2001 | 0 | 43 | 43 |
| 2002 | 0 | 61 | 61 |
| 2003 | 0 | 40 | 40 |
| 2004 | 1 | 56 | 57 |
| 2005 | 0 | 43 | 43 |
| 2006 | 0 | 62 | 62 |
| 2007 | 0 | 62 | 62 |
| 2008 | 0 | 51 | 51 |
| 2009 | 0 | 67 | 67 |
| 2010 | 0 | 65 | 65 |
| 2011 | 0 | 79 | 79 |
| 2012 | 1 | 57 | 58 |
| 2013 | 0 | 71 | 71 |
| 2014 | 0 | 56 | 56 |
| 2015 | 0 | 52 | 52 |
| 2016 | 0 | 66 | 66 |
| 2017 | 0 | 41 | 41 |
| 2018 | 0 | 62 | 62 |
| 2019 | 0 | 32 | 32 |
| 2020 | 0 | 57 | 57 |
| 2021 | 0 | 44 | 44 |
| 2022 | 0 | 9 | 9 |
| 2023 | 0 | 5 | 5 |
| 2024 | 2 | 12 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Inbred BALB C" by people in Profiles.
-
Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity. Int Immunopharmacol. 2024 Dec 05; 142(Pt A):113004.
-
Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe. 2024 Sep 11; 32(9):1621-1636.e6.
-
The EEHV1A gH/gL complex elicits humoral and cell-mediated immune responses in mice. Vaccine. 2024 Oct 03; 42(23):126227.
-
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters. Nat Commun. 2024 Jul 23; 15(1):6193.
-
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system Commun Biol. 2024 07 17; 7(1):871.
-
A combined radio-immunotherapy regimen eradicates late-stage tumors in mice. Front Immunol. 2024; 15:1419773.
-
The effect of ADAMTS13 on graft-versus-host disease. J Cell Mol Med. 2024 Jul; 28(13):e18457.
-
Ultra-pH-sensitive nanoparticle of gambogenic acid for tumor targeting therapy via anti-vascular strategy plus immunotherapy. Int J Pharm. 2024 Jul 20; 660:124303.
-
Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head. Nat Commun. 2024 May 27; 15(1):4505.
-
Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection. Int Immunopharmacol. 2024 Jun 15; 134:112100.